

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.21931710 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.21931710 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.15354735 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.06637662 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.85670428 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.72086145 |
| 7 | negative regulation of cell killing (GO:0031342) | 4.52656163 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.52656163 |
| 9 | leukocyte aggregation (GO:0070486) | 4.35149326 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.20591431 |
| 11 | negative thymic T cell selection (GO:0045060) | 3.95508548 |
| 12 | negative T cell selection (GO:0043383) | 3.90777314 |
| 13 | * Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.89165576 |
| 14 | positive thymic T cell selection (GO:0045059) | 3.83958667 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.82837376 |
| 16 | detection of molecule of bacterial origin (GO:0032490) | 3.67621938 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 3.57633045 |
| 18 | B cell receptor signaling pathway (GO:0050853) | 3.54557999 |
| 19 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.52811853 |
| 20 | detection of other organism (GO:0098543) | 3.46506288 |
| 21 | regulation of B cell differentiation (GO:0045577) | 3.43912483 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.42117226 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.42117226 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.42117226 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 3.42117226 |
| 26 | positive regulation by symbiont of host defense response (GO:0052509) | 3.42117226 |
| 27 | modulation by symbiont of host defense response (GO:0052031) | 3.42117226 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 3.40189009 |
| 29 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.37225886 |
| 30 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.30023237 |
| 31 | negative regulation of phagocytosis (GO:0050765) | 3.29422390 |
| 32 | thymic T cell selection (GO:0045061) | 3.27794465 |
| 33 | protein localization to endosome (GO:0036010) | 3.26520016 |
| 34 | detection of external biotic stimulus (GO:0098581) | 3.25905935 |
| 35 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.25360856 |
| 36 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.24860026 |
| 37 | neutrophil activation involved in immune response (GO:0002283) | 3.20417566 |
| 38 | response to interleukin-15 (GO:0070672) | 3.19785717 |
| 39 | T cell migration (GO:0072678) | 3.17410215 |
| 40 | leukocyte cell-cell adhesion (GO:0007159) | 3.15902693 |
| 41 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.14809829 |
| 42 | positive regulation of B cell differentiation (GO:0045579) | 3.12579970 |
| 43 | cellular response to zinc ion (GO:0071294) | 3.12009806 |
| 44 | hepatocyte apoptotic process (GO:0097284) | 3.09836485 |
| 45 | detection of bacterium (GO:0016045) | 3.07733851 |
| 46 | positive T cell selection (GO:0043368) | 3.05767009 |
| 47 | positive regulation of interferon-alpha production (GO:0032727) | 3.05633502 |
| 48 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.00940475 |
| 49 | cellular extravasation (GO:0045123) | 3.00781574 |
| 50 | respiratory burst (GO:0045730) | 2.99969730 |
| 51 | T cell selection (GO:0045058) | 2.99927395 |
| 52 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.98888549 |
| 53 | NIK/NF-kappaB signaling (GO:0038061) | 2.98223411 |
| 54 | B cell mediated immunity (GO:0019724) | 2.96996303 |
| 55 | regulation of interferon-alpha production (GO:0032647) | 2.96134318 |
| 56 | interferon-gamma production (GO:0032609) | 2.91034870 |
| 57 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.89019631 |
| 58 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.87694194 |
| 59 | tolerance induction (GO:0002507) | 2.87424743 |
| 60 | detection of biotic stimulus (GO:0009595) | 2.86280862 |
| 61 | membrane raft organization (GO:0031579) | 2.85830639 |
| 62 | pinocytosis (GO:0006907) | 2.85698022 |
| 63 | * actin nucleation (GO:0045010) | 2.83199549 |
| 64 | T cell costimulation (GO:0031295) | 2.82987615 |
| 65 | regulation of tolerance induction (GO:0002643) | 2.81529394 |
| 66 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.81194685 |
| 67 | negative regulation of T cell mediated immunity (GO:0002710) | 2.79970270 |
| 68 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.79425308 |
| 69 | lymphocyte costimulation (GO:0031294) | 2.78764918 |
| 70 | cellular response to interleukin-15 (GO:0071350) | 2.78713150 |
| 71 | regulation of T cell tolerance induction (GO:0002664) | 2.78573884 |
| 72 | germinal center formation (GO:0002467) | 2.77227175 |
| 73 | negative regulation of interleukin-12 production (GO:0032695) | 2.76867167 |
| 74 | myeloid dendritic cell activation (GO:0001773) | 2.73273150 |
| 75 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.72321185 |
| 76 | positive regulation of isotype switching (GO:0045830) | 2.72156915 |
| 77 | neutrophil activation (GO:0042119) | 2.71403945 |
| 78 | regulation of response to interferon-gamma (GO:0060330) | 2.69438844 |
| 79 | hypotonic response (GO:0006971) | 2.68675526 |
| 80 | positive regulation of macrophage differentiation (GO:0045651) | 2.66249989 |
| 81 | response to host immune response (GO:0052572) | 2.66123845 |
| 82 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.66123845 |
| 83 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.64611541 |
| 84 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.63083345 |
| 85 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.62988780 |
| 86 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.62948236 |
| 87 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.62850497 |
| 88 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.62678956 |
| 89 | response to peptidoglycan (GO:0032494) | 2.62326759 |
| 90 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.61425600 |
| 91 | * positive regulation of lamellipodium assembly (GO:0010592) | 2.60919319 |
| 92 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.60480310 |
| 93 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.58797356 |
| 94 | response to host (GO:0075136) | 2.58797356 |
| 95 | response to host defenses (GO:0052200) | 2.58797356 |
| 96 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.58333569 |
| 97 | negative regulation of interleukin-17 production (GO:0032700) | 2.58085028 |
| 98 | T-helper 1 type immune response (GO:0042088) | 2.57182261 |
| 99 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.56949287 |
| 100 | macrophage activation involved in immune response (GO:0002281) | 2.56397172 |
| 101 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.55316616 |
| 102 | natural killer cell mediated immunity (GO:0002228) | 2.54993929 |
| 103 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.54993929 |
| 104 | negative regulation of B cell proliferation (GO:0030889) | 2.54772250 |
| 105 | granulocyte activation (GO:0036230) | 2.54382792 |
| 106 | myeloid dendritic cell differentiation (GO:0043011) | 2.52540402 |
| 107 | response to muramyl dipeptide (GO:0032495) | 2.51820391 |
| 108 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.51284455 |
| 109 | response to protozoan (GO:0001562) | 2.51242601 |
| 110 | positive regulation of macrophage cytokine production (GO:0060907) | 2.51193798 |
| 111 | response to type I interferon (GO:0034340) | 2.48689144 |
| 112 | positive regulation of antigen processing and presentation (GO:0002579) | 2.47656329 |
| 113 | myeloid cell activation involved in immune response (GO:0002275) | 2.45825595 |
| 114 | regulation of macrophage cytokine production (GO:0010935) | 2.45152416 |
| 115 | cellular response to type I interferon (GO:0071357) | 2.44765601 |
| 116 | type I interferon signaling pathway (GO:0060337) | 2.44765601 |
| 117 | T cell homeostasis (GO:0043029) | 2.44732539 |
| 118 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.44726720 |
| 119 | regulation of mast cell degranulation (GO:0043304) | 2.44076316 |
| 120 | macrophage activation (GO:0042116) | 2.44002162 |
| 121 | T cell proliferation (GO:0042098) | 2.43993681 |
| 122 | positive regulation of interleukin-2 production (GO:0032743) | 2.43510262 |
| 123 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.42755585 |
| 124 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.42399969 |
| 125 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.42360591 |
| 126 | lymphocyte homeostasis (GO:0002260) | 2.42182617 |
| 127 | mast cell activation (GO:0045576) | 2.41844747 |
| 128 | T cell receptor signaling pathway (GO:0050852) | 2.39322449 |
| 129 | natural killer cell differentiation (GO:0001779) | 2.39000008 |
| 130 | defense response to protozoan (GO:0042832) | 2.38942511 |
| 131 | regulation of necroptotic process (GO:0060544) | 2.37747066 |
| 132 | mature B cell differentiation (GO:0002335) | 2.37186964 |
| 133 | positive regulation of interferon-beta production (GO:0032728) | 2.37067412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.73286942 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.30004476 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.13603085 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.06189579 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.69491377 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.60306802 |
| 7 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.20942663 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.13252300 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 3.02755734 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.97400993 |
| 11 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.94442681 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.89361891 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.82576028 |
| 14 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.59334015 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.57243930 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.56791408 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54131548 |
| 18 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50067956 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.44573942 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.44377436 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.29202050 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.25173749 |
| 23 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.23962308 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.23285255 |
| 25 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.18022122 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.17516547 |
| 27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.11993321 |
| 28 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.09516166 |
| 29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.08875789 |
| 30 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.07867087 |
| 31 | * MYB_26560356_Chip-Seq_TH1_Human | 2.05568079 |
| 32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.00445318 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.98679218 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.95329835 |
| 35 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.89399424 |
| 36 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.86120164 |
| 37 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84877990 |
| 38 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.83626079 |
| 39 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81139778 |
| 40 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.76551936 |
| 41 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.67937428 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.62741683 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.57858642 |
| 44 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57765574 |
| 45 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.57362199 |
| 46 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54945907 |
| 47 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.52144433 |
| 48 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.51456674 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51438150 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.50774283 |
| 51 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.48600979 |
| 52 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.45457645 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43691247 |
| 54 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.40929752 |
| 55 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.39985844 |
| 56 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.39484858 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.38145227 |
| 58 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.37791452 |
| 59 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.33919770 |
| 60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.30381938 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.30346835 |
| 62 | * MAF_26560356_Chip-Seq_TH2_Human | 1.28333936 |
| 63 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.25164452 |
| 64 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24648628 |
| 65 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.24490007 |
| 66 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24018475 |
| 67 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.18564453 |
| 68 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.17114960 |
| 69 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.14982660 |
| 70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13647009 |
| 71 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.13627487 |
| 72 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.12777625 |
| 73 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.12476635 |
| 74 | GATA1_22025678_ChIP-Seq_K562_Human | 1.10965573 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09869712 |
| 76 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.09712160 |
| 77 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09705627 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09265202 |
| 79 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09075110 |
| 80 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.08090207 |
| 81 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06724109 |
| 82 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04296838 |
| 83 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03241419 |
| 84 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.01661612 |
| 85 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01627449 |
| 86 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.01528278 |
| 87 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01214311 |
| 88 | GATA3_26560356_Chip-Seq_TH2_Human | 1.00520166 |
| 89 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00133955 |
| 90 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.99870972 |
| 91 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97351899 |
| 92 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.96843506 |
| 93 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94794956 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93832934 |
| 95 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91615797 |
| 96 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.91544827 |
| 97 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89475791 |
| 98 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89442937 |
| 99 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87864111 |
| 100 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87827067 |
| 101 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.86921273 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86573254 |
| 103 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86560114 |
| 104 | * ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.85771802 |
| 105 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.85730937 |
| 106 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.83293203 |
| 107 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.82948917 |
| 108 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.82541675 |
| 109 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.81924653 |
| 110 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.80882416 |
| 111 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80285777 |
| 112 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80231790 |
| 113 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79634424 |
| 114 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79261966 |
| 115 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.78920899 |
| 116 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.78920899 |
| 117 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.78811957 |
| 118 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.78341459 |
| 119 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.76692996 |
| 120 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.75461177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.73807089 |
| 2 | MP0003303_peritoneal_inflammation | 3.19497609 |
| 3 | MP0000685_abnormal_immune_system | 2.93185345 |
| 4 | MP0003436_decreased_susceptibility_to | 2.87363701 |
| 5 | MP0001800_abnormal_humoral_immune | 2.72140636 |
| 6 | MP0005671_abnormal_response_to | 2.69848905 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.61443829 |
| 8 | MP0001790_abnormal_immune_system | 2.59920277 |
| 9 | MP0005387_immune_system_phenotype | 2.59920277 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.59659833 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.54949999 |
| 12 | MP0009785_altered_susceptibility_to | 2.52915673 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.51540233 |
| 14 | MP0010352_gastrointestinal_tract_polyps | 2.49784922 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.38700270 |
| 16 | MP0001819_abnormal_immune_cell | 2.37313041 |
| 17 | MP0002723_abnormal_immune_serum | 2.32372585 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.32194817 |
| 19 | MP0002419_abnormal_innate_immunity | 2.29098407 |
| 20 | MP0005025_abnormal_response_to | 2.27831551 |
| 21 | MP0002396_abnormal_hematopoietic_system | 2.26297731 |
| 22 | MP0002398_abnormal_bone_marrow | 2.20470856 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.11653351 |
| 24 | MP0002405_respiratory_system_inflammati | 2.06850714 |
| 25 | MP0002006_tumorigenesis | 1.99877884 |
| 26 | MP0000716_abnormal_immune_system | 1.96662181 |
| 27 | MP0006082_CNS_inflammation | 1.93572611 |
| 28 | MP0004947_skin_inflammation | 1.93300763 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.88971454 |
| 30 | MP0008260_abnormal_autophagy | 1.84971899 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.84480616 |
| 32 | MP0004808_abnormal_hematopoietic_stem | 1.83641168 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.83588845 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.79648835 |
| 35 | MP0002722_abnormal_immune_system | 1.77649402 |
| 36 | MP0001853_heart_inflammation | 1.74432275 |
| 37 | MP0001873_stomach_inflammation | 1.74170729 |
| 38 | MP0004510_myositis | 1.71799090 |
| 39 | MP0005451_abnormal_body_composition | 1.71005193 |
| 40 | MP0002429_abnormal_blood_cell | 1.67878987 |
| 41 | MP0005076_abnormal_cell_differentiation | 1.67532460 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.62682216 |
| 43 | MP0003566_abnormal_cell_adhesion | 1.60463956 |
| 44 | MP0000858_altered_metastatic_potential | 1.59875512 |
| 45 | MP0006054_spinal_hemorrhage | 1.59345820 |
| 46 | MP0009278_abnormal_bone_marrow | 1.57786235 |
| 47 | MP0000703_abnormal_thymus_morphology | 1.56394087 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.54866742 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.54866742 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.54170731 |
| 51 | MP0010307_abnormal_tumor_latency | 1.51492931 |
| 52 | MP0003448_altered_tumor_morphology | 1.51261390 |
| 53 | MP0003724_increased_susceptibility_to | 1.51142866 |
| 54 | MP0010234_abnormal_vibrissa_follicle | 1.47075580 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.45902216 |
| 56 | MP0000490_abnormal_crypts_of | 1.45292465 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 1.45286878 |
| 58 | MP0003693_abnormal_embryo_hatching | 1.43975934 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.42806104 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.38731440 |
| 61 | MP0003866_abnormal_defecation | 1.36230831 |
| 62 | MP0002933_joint_inflammation | 1.33012491 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.25135407 |
| 64 | MP0005310_abnormal_salivary_gland | 1.24759211 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.23610491 |
| 66 | MP0005023_abnormal_wound_healing | 1.23270031 |
| 67 | MP0003183_abnormal_peptide_metabolism | 1.22162848 |
| 68 | MP0002877_abnormal_melanocyte_morpholog | 1.20723039 |
| 69 | MP0004883_abnormal_blood_vessel | 1.15927209 |
| 70 | MP0005164_abnormal_response_to | 1.13524302 |
| 71 | MP0003077_abnormal_cell_cycle | 1.12831137 |
| 72 | MP0002019_abnormal_tumor_incidence | 1.09958894 |
| 73 | MP0003221_abnormal_cardiomyocyte_apopto | 1.08830643 |
| 74 | MP0003091_abnormal_cell_migration | 1.05926548 |
| 75 | MP0010094_abnormal_chromosome_stability | 1.03044199 |
| 76 | MP0008469_abnormal_protein_level | 1.01151806 |
| 77 | MP0008057_abnormal_DNA_replication | 0.98907590 |
| 78 | MP0000343_altered_response_to | 0.97770649 |
| 79 | MP0009840_abnormal_foam_cell | 0.97102703 |
| 80 | MP0003111_abnormal_nucleus_morphology | 0.95389084 |
| 81 | MP0005174_abnormal_tail_pigmentation | 0.92743104 |
| 82 | * MP0004957_abnormal_blastocyst_morpholog | 0.92512352 |
| 83 | MP0001851_eye_inflammation | 0.92336997 |
| 84 | MP0009763_increased_sensitivity_to | 0.89543863 |
| 85 | MP0002998_abnormal_bone_remodeling | 0.89161581 |
| 86 | MP0008007_abnormal_cellular_replicative | 0.89134739 |
| 87 | MP0002009_preneoplasia | 0.87247769 |
| 88 | MP0003950_abnormal_plasma_membrane | 0.86915912 |
| 89 | MP0003828_pulmonary_edema | 0.86692972 |
| 90 | MP0000015_abnormal_ear_pigmentation | 0.84091154 |
| 91 | MP0003279_aneurysm | 0.83456763 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.82375861 |
| 93 | MP0000350_abnormal_cell_proliferation | 0.81949533 |
| 94 | MP0005275_abnormal_skin_tensile | 0.81479256 |
| 95 | MP0008004_abnormal_stomach_pH | 0.80785361 |
| 96 | MP0001958_emphysema | 0.79279077 |
| 97 | MP0001542_abnormal_bone_strength | 0.74973224 |
| 98 | MP0001915_intracranial_hemorrhage | 0.74378882 |
| 99 | MP0005166_decreased_susceptibility_to | 0.72014546 |
| 100 | MP0008438_abnormal_cutaneous_collagen | 0.71565509 |
| 101 | MP0005390_skeleton_phenotype | 0.70746666 |
| 102 | MP0003795_abnormal_bone_structure | 0.70723076 |
| 103 | MP0000313_abnormal_cell_death | 0.67715669 |
| 104 | MP0003045_fibrosis | 0.66952614 |
| 105 | MP0000477_abnormal_intestine_morphology | 0.66695033 |
| 106 | MP0003191_abnormal_cellular_cholesterol | 0.65937917 |
| 107 | MP0000249_abnormal_blood_vessel | 0.65866228 |
| 108 | MP0005621_abnormal_cell_physiology | 0.65332172 |
| 109 | MP0003075_altered_response_to | 0.64731007 |
| 110 | * MP0001730_embryonic_growth_arrest | 0.63551519 |
| 111 | MP0000371_diluted_coat_color | 0.62988795 |
| 112 | MP0009764_decreased_sensitivity_to | 0.62671765 |
| 113 | MP0002086_abnormal_extraembryonic_tissu | 0.61815795 |
| 114 | MP0000604_amyloidosis | 0.61155698 |
| 115 | MP0001216_abnormal_epidermal_layer | 0.58957869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.98587720 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.73404533 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.11344754 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.83281769 |
| 5 | Myositis (HP:0100614) | 3.81299036 |
| 6 | Recurrent viral infections (HP:0004429) | 3.80976293 |
| 7 | Recurrent fungal infections (HP:0002841) | 3.79330606 |
| 8 | IgM deficiency (HP:0002850) | 3.38278698 |
| 9 | T lymphocytopenia (HP:0005403) | 3.38013152 |
| 10 | Chronic otitis media (HP:0000389) | 3.36529980 |
| 11 | Abnormality of T cell number (HP:0011839) | 3.29755382 |
| 12 | Recurrent bronchitis (HP:0002837) | 3.28581241 |
| 13 | Cellulitis (HP:0100658) | 3.27792279 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.24470795 |
| 15 | Abnormality of glycolipid metabolism (HP:0010969) | 3.17394104 |
| 16 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.17394104 |
| 17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.17394104 |
| 18 | Thrombocytosis (HP:0001894) | 3.12228875 |
| 19 | Abnormality of T cells (HP:0002843) | 3.06237308 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.99864256 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 2.99398204 |
| 22 | Obstructive lung disease (HP:0006536) | 2.99398204 |
| 23 | Autoimmune thrombocytopenia (HP:0001973) | 2.95156575 |
| 24 | Orchitis (HP:0100796) | 2.92335536 |
| 25 | Meningitis (HP:0001287) | 2.86815653 |
| 26 | Abnormality of macrophages (HP:0004311) | 2.85861870 |
| 27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.83240527 |
| 28 | Nasal polyposis (HP:0100582) | 2.82887704 |
| 29 | Pustule (HP:0200039) | 2.81712880 |
| 30 | Recurrent skin infections (HP:0001581) | 2.78714492 |
| 31 | Myocardial infarction (HP:0001658) | 2.77887388 |
| 32 | Vasculitis (HP:0002633) | 2.75395540 |
| 33 | Lymphopenia (HP:0001888) | 2.69242886 |
| 34 | Autoimmune hemolytic anemia (HP:0001890) | 2.69118610 |
| 35 | Abnormality of T cell physiology (HP:0011840) | 2.68613588 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.67332848 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 2.67332848 |
| 38 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.64933167 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 2.64247753 |
| 40 | Optic neuritis (HP:0100653) | 2.64247753 |
| 41 | Inflammation of the large intestine (HP:0002037) | 2.60212821 |
| 42 | Interstitial pulmonary disease (HP:0006530) | 2.58914926 |
| 43 | Gastrointestinal inflammation (HP:0004386) | 2.57820756 |
| 44 | Panhypogammaglobulinemia (HP:0003139) | 2.56965278 |
| 45 | Arterial thrombosis (HP:0004420) | 2.56852377 |
| 46 | Hematochezia (HP:0002573) | 2.54701693 |
| 47 | Abnormality of the nasal mucosa (HP:0000433) | 2.54213004 |
| 48 | Stomatitis (HP:0010280) | 2.52437414 |
| 49 | Urticaria (HP:0001025) | 2.51144600 |
| 50 | Gingivitis (HP:0000230) | 2.48608941 |
| 51 | Spontaneous hematomas (HP:0007420) | 2.46812268 |
| 52 | Increased density of long bones (HP:0006392) | 2.46621450 |
| 53 | Periodontitis (HP:0000704) | 2.43880551 |
| 54 | IgA deficiency (HP:0002720) | 2.42923084 |
| 55 | Increased cerebral lipofuscin (HP:0011813) | 2.41037168 |
| 56 | Colitis (HP:0002583) | 2.40347764 |
| 57 | Leukocytosis (HP:0001974) | 2.40117995 |
| 58 | Increased IgE level (HP:0003212) | 2.38205230 |
| 59 | Agammaglobulinemia (HP:0004432) | 2.38093574 |
| 60 | Chest pain (HP:0100749) | 2.36334220 |
| 61 | Eosinophilia (HP:0001880) | 2.30624389 |
| 62 | Pulmonary infiltrates (HP:0002113) | 2.29722530 |
| 63 | IgG deficiency (HP:0004315) | 2.28992667 |
| 64 | Gingival bleeding (HP:0000225) | 2.28076480 |
| 65 | Peritonitis (HP:0002586) | 2.27929169 |
| 66 | Thyroiditis (HP:0100646) | 2.27697612 |
| 67 | Premature rupture of membranes (HP:0001788) | 2.27330938 |
| 68 | Osteomyelitis (HP:0002754) | 2.27112734 |
| 69 | Increased IgM level (HP:0003496) | 2.25880854 |
| 70 | B lymphocytopenia (HP:0010976) | 2.25638636 |
| 71 | Abnormality of B cell number (HP:0010975) | 2.25638636 |
| 72 | Verrucae (HP:0200043) | 2.23980802 |
| 73 | Papilloma (HP:0012740) | 2.23980802 |
| 74 | Combined immunodeficiency (HP:0005387) | 2.22304365 |
| 75 | Spondylolisthesis (HP:0003302) | 2.22067933 |
| 76 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.18703351 |
| 77 | Osteolytic defects of the hand bones (HP:0009699) | 2.18703351 |
| 78 | Gastrointestinal stroma tumor (HP:0100723) | 2.18447770 |
| 79 | Disinhibition (HP:0000734) | 2.17870009 |
| 80 | Papilledema (HP:0001085) | 2.17780163 |
| 81 | Epistaxis (HP:0000421) | 2.17363854 |
| 82 | Severe combined immunodeficiency (HP:0004430) | 2.14432277 |
| 83 | Emphysema (HP:0002097) | 2.12612289 |
| 84 | Skin ulcer (HP:0200042) | 2.12418868 |
| 85 | Glomerulopathy (HP:0100820) | 2.10203621 |
| 86 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.09929756 |
| 87 | Loss of speech (HP:0002371) | 2.09631224 |
| 88 | Abnormal platelet volume (HP:0011876) | 2.07630622 |
| 89 | Keratoconjunctivitis (HP:0001096) | 2.06628622 |
| 90 | Abnormality of the fingertips (HP:0001211) | 2.06534641 |
| 91 | Granulocytopenia (HP:0001913) | 2.05081914 |
| 92 | Vacuolated lymphocytes (HP:0001922) | 2.03389168 |
| 93 | Amaurosis fugax (HP:0100576) | 2.02444015 |
| 94 | Hemoptysis (HP:0002105) | 2.01723473 |
| 95 | Abnormality of the peritoneum (HP:0002585) | 2.00968262 |
| 96 | Abnormality of eosinophils (HP:0001879) | 2.00743369 |
| 97 | Cerebral aneurysm (HP:0004944) | 2.00087977 |
| 98 | Lymphoma (HP:0002665) | 1.98441929 |
| 99 | Hypergammaglobulinemia (HP:0010702) | 1.98006682 |
| 100 | Thick nail (HP:0001805) | 1.95511669 |
| 101 | Keratoconjunctivitis sicca (HP:0001097) | 1.95398914 |
| 102 | Chronic diarrhea (HP:0002028) | 1.95198033 |
| 103 | Petechiae (HP:0000967) | 1.94606389 |
| 104 | Gastrointestinal infarctions (HP:0005244) | 1.92900394 |
| 105 | Encephalitis (HP:0002383) | 1.92698782 |
| 106 | Spinal cord lesions (HP:0100561) | 1.91224350 |
| 107 | Syringomyelia (HP:0003396) | 1.91224350 |
| 108 | Viral hepatitis (HP:0006562) | 1.90521109 |
| 109 | Aortic dissection (HP:0002647) | 1.90481037 |
| 110 | Dysostosis multiplex (HP:0000943) | 1.89723245 |
| 111 | Increased mean platelet volume (HP:0011877) | 1.89209167 |
| 112 | Agnosia (HP:0010524) | 1.88646393 |
| 113 | Hepatosplenomegaly (HP:0001433) | 1.88513345 |
| 114 | Recurrent lower respiratory tract infections (HP:0002783) | 1.87427097 |
| 115 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.85990384 |
| 116 | Fatigue (HP:0012378) | 1.85605244 |
| 117 | Premature loss of primary teeth (HP:0006323) | 1.85267846 |
| 118 | Aortic aneurysm (HP:0004942) | 1.84682513 |
| 119 | Sepsis (HP:0100806) | 1.84652086 |
| 120 | Cutaneous melanoma (HP:0012056) | 1.84062591 |
| 121 | Subacute progressive viral hepatitis (HP:0006572) | 1.83471183 |
| 122 | Recurrent pneumonia (HP:0006532) | 1.83092112 |
| 123 | Dilatation of the ascending aorta (HP:0005111) | 1.83038066 |
| 124 | Restrictive lung disease (HP:0002091) | 1.82777472 |
| 125 | Gangrene (HP:0100758) | 1.81531224 |
| 126 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.81050427 |
| 127 | Slow saccadic eye movements (HP:0000514) | 1.80490315 |
| 128 | Prolonged bleeding time (HP:0003010) | 1.78797391 |
| 129 | Abnormality of oral frenula (HP:0000190) | 1.78438892 |
| 130 | Abnormality of the prostate (HP:0008775) | 1.77386777 |
| 131 | Polycythemia (HP:0001901) | 1.77208221 |
| 132 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.76981312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.38450166 |
| 2 | PRPF4B | 2.77791805 |
| 3 | STK10 | 2.77656775 |
| 4 | JAK3 | 2.48559174 |
| 5 | BLK | 2.47145722 |
| 6 | TXK | 2.46701101 |
| 7 | TYK2 | 2.28313459 |
| 8 | ZAP70 | 2.25656721 |
| 9 | TRIB3 | 2.23231547 |
| 10 | BMPR2 | 2.19168671 |
| 11 | PKN2 | 2.14803433 |
| 12 | MAP3K14 | 1.89184727 |
| 13 | LRRK2 | 1.89117047 |
| 14 | TBK1 | 1.87499495 |
| 15 | ITK | 1.86642472 |
| 16 | RPS6KA4 | 1.82901822 |
| 17 | ERN1 | 1.82104331 |
| 18 | EEF2K | 1.79932931 |
| 19 | MAP3K10 | 1.78316877 |
| 20 | RIPK4 | 1.76531727 |
| 21 | TESK2 | 1.71242051 |
| 22 | GRK6 | 1.70348316 |
| 23 | BTK | 1.68682391 |
| 24 | IRAK4 | 1.68195206 |
| 25 | KIT | 1.64638798 |
| 26 | SCYL2 | 1.63032928 |
| 27 | CSK | 1.59589955 |
| 28 | JAK1 | 1.59346215 |
| 29 | SYK | 1.52636468 |
| 30 | TEC | 1.49934980 |
| 31 | PIK3CG | 1.46824013 |
| 32 | TESK1 | 1.44727413 |
| 33 | CSF1R | 1.43177063 |
| 34 | TTN | 1.41120356 |
| 35 | IKBKE | 1.35995660 |
| 36 | SIK3 | 1.33449572 |
| 37 | HCK | 1.32512291 |
| 38 | LCK | 1.29815464 |
| 39 | MAP3K13 | 1.29291986 |
| 40 | FGFR3 | 1.28839093 |
| 41 | KDR | 1.24797502 |
| 42 | NEK2 | 1.20832083 |
| 43 | MAP2K3 | 1.16513364 |
| 44 | CDC7 | 1.15131374 |
| 45 | TAOK2 | 1.14551725 |
| 46 | IKBKB | 1.10497395 |
| 47 | RIPK1 | 1.10227959 |
| 48 | MOS | 1.10177305 |
| 49 | FGFR4 | 1.09809039 |
| 50 | MST4 | 1.07279366 |
| 51 | MARK3 | 1.04070481 |
| 52 | MAP3K8 | 1.01847924 |
| 53 | PTK6 | 1.01766041 |
| 54 | PIM1 | 0.98347588 |
| 55 | NEK9 | 0.98072669 |
| 56 | GRK7 | 0.95258714 |
| 57 | LYN | 0.94691614 |
| 58 | TGFBR2 | 0.93511561 |
| 59 | PAK4 | 0.93171168 |
| 60 | FES | 0.92698775 |
| 61 | CDK12 | 0.92215317 |
| 62 | PDGFRA | 0.91361046 |
| 63 | CLK1 | 0.89946589 |
| 64 | FLT3 | 0.89293324 |
| 65 | NME2 | 0.87023507 |
| 66 | TRPM7 | 0.84239373 |
| 67 | CHUK | 0.83880646 |
| 68 | CDK6 | 0.82669858 |
| 69 | KSR1 | 0.82581398 |
| 70 | CAMKK2 | 0.82262586 |
| 71 | CDK4 | 0.80284032 |
| 72 | ALK | 0.80277712 |
| 73 | EPHB1 | 0.79559224 |
| 74 | MAP3K1 | 0.77318894 |
| 75 | MAP3K2 | 0.76558492 |
| 76 | JAK2 | 0.75229788 |
| 77 | MAP3K6 | 0.74630585 |
| 78 | YES1 | 0.73066110 |
| 79 | TGFBR1 | 0.71284065 |
| 80 | ACVR1B | 0.71040331 |
| 81 | PIM2 | 0.70588773 |
| 82 | STK4 | 0.66694264 |
| 83 | MYLK | 0.64892516 |
| 84 | TAOK3 | 0.64210807 |
| 85 | RPS6KB2 | 0.61219729 |
| 86 | SIK2 | 0.60944985 |
| 87 | DMPK | 0.60577924 |
| 88 | PRKCQ | 0.60348778 |
| 89 | IRAK1 | 0.58605857 |
| 90 | BRD4 | 0.55959936 |
| 91 | DDR2 | 0.55273257 |
| 92 | MAP3K3 | 0.54693970 |
| 93 | MAP3K11 | 0.54561920 |
| 94 | TAOK1 | 0.54385935 |
| 95 | RAF1 | 0.53437542 |
| 96 | EPHA3 | 0.52183204 |
| 97 | SMG1 | 0.51948755 |
| 98 | CDC42BPA | 0.51794673 |
| 99 | EGFR | 0.50698880 |
| 100 | MATK | 0.50325884 |
| 101 | PRKCH | 0.49310634 |
| 102 | MAPKAPK2 | 0.48240589 |
| 103 | EIF2AK3 | 0.47639877 |
| 104 | PDGFRB | 0.47455044 |
| 105 | EIF2AK1 | 0.45607221 |
| 106 | IRAK2 | 0.44067083 |
| 107 | STK3 | 0.43692400 |
| 108 | MELK | 0.43613273 |
| 109 | NLK | 0.43017301 |
| 110 | ATR | 0.41942879 |
| 111 | PDK1 | 0.41397121 |
| 112 | ABL1 | 0.41227780 |
| 113 | IRAK3 | 0.41133937 |
| 114 | FRK | 0.40910453 |
| 115 | MAPK7 | 0.40485020 |
| 116 | MAP3K5 | 0.39878252 |
| 117 | KSR2 | 0.38894191 |
| 118 | PRKG2 | 0.38800790 |
| 119 | ILK | 0.38607762 |
| 120 | STK24 | 0.38249525 |
| 121 | FYN | 0.37661796 |
| 122 | BRSK2 | 0.37380306 |
| 123 | MAP3K12 | 0.37021079 |
| 124 | MAPK11 | 0.36824373 |
| 125 | AURKB | 0.36390829 |
| 126 | FGR | 0.36281538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.80300880 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.63961374 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.30811028 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.29202519 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.09805188 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.08459285 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.98489692 |
| 8 | Measles_Homo sapiens_hsa05162 | 1.91346063 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.88492306 |
| 10 | Shigellosis_Homo sapiens_hsa05131 | 1.86771904 |
| 11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.85969511 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.79614629 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.77823517 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75790616 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.68243732 |
| 16 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.64216208 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 1.63897267 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.62707762 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.61403399 |
| 20 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.60863662 |
| 21 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.60731462 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54983420 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.49511637 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.47537781 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.46874395 |
| 26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.45974629 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44286987 |
| 28 | DNA replication_Homo sapiens_hsa03030 | 1.43242580 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.41772665 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.39169718 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.36102923 |
| 32 | Hepatitis B_Homo sapiens_hsa05161 | 1.36013050 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.34100942 |
| 34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33630589 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.33374892 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33082158 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32104554 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29376722 |
| 39 | Influenza A_Homo sapiens_hsa05164 | 1.27165017 |
| 40 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24807882 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.24723702 |
| 42 | Malaria_Homo sapiens_hsa05144 | 1.18464000 |
| 43 | Platelet activation_Homo sapiens_hsa04611 | 1.14847998 |
| 44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14413800 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.09954852 |
| 46 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.09091935 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08799243 |
| 48 | Asthma_Homo sapiens_hsa05310 | 1.06494541 |
| 49 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.05793012 |
| 50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.03319520 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.02811839 |
| 52 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.02743127 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.02344191 |
| 54 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.02088975 |
| 55 | HTLV-I infection_Homo sapiens_hsa05166 | 1.01368803 |
| 56 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.00073000 |
| 57 | Lysosome_Homo sapiens_hsa04142 | 0.94474161 |
| 58 | Cell cycle_Homo sapiens_hsa04110 | 0.90742319 |
| 59 | Colorectal cancer_Homo sapiens_hsa05210 | 0.88446531 |
| 60 | Base excision repair_Homo sapiens_hsa03410 | 0.88319094 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 0.86565564 |
| 62 | Mismatch repair_Homo sapiens_hsa03430 | 0.86394512 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85432683 |
| 64 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84791275 |
| 65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.82324815 |
| 66 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82055417 |
| 67 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.78051995 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.77857753 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77270402 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 0.76702808 |
| 71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76284388 |
| 72 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.75950919 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.75550182 |
| 74 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.75047558 |
| 75 | Adherens junction_Homo sapiens_hsa04520 | 0.74144985 |
| 76 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73595524 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.73129336 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71680261 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69998174 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.69131791 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66677468 |
| 82 | Focal adhesion_Homo sapiens_hsa04510 | 0.64503227 |
| 83 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64221598 |
| 84 | Spliceosome_Homo sapiens_hsa03040 | 0.62571702 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.62545478 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.62306977 |
| 87 | RNA transport_Homo sapiens_hsa03013 | 0.59544450 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58367962 |
| 89 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.56125759 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50703812 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49150526 |
| 92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47678803 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47455472 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46909457 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45167136 |
| 96 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43628177 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.43515265 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43297538 |
| 99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43250262 |
| 100 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.43214827 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.42292595 |
| 102 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.41323173 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.39488964 |
| 104 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.38721172 |
| 105 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38602993 |
| 106 | Homologous recombination_Homo sapiens_hsa03440 | 0.38363810 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37530845 |
| 108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.37153978 |
| 109 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37109766 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34446312 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31751520 |
| 112 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.31626538 |
| 113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31019041 |
| 114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30656618 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30175078 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30008315 |

